Nuvation Bio Inc.

General ticker "NUVB-WT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.6B (TTM average)

Nuvation Bio Inc. does not follow the US Stock Market performance with the rate: -20.5%.

Estimated limits based on current volatility of 5.0%: low 0.07$, high 0.08$

Factors to consider:

  • Total employees count: 298 (+35.5%) as of 2025
  • China accounted for 66.0% of revenue in the fiscal year ended 2024-12-31
  • Top business risk factors: Dependence on IBTROZI, Regulatory and compliance, Need for additional capital, Intellectual property risks, Market competition
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [0.22$, 0.61$]
  • 2026-12-31 to 2027-12-31 estimated range: [0.19$, 0.54$]

Similar symbols

Short-term NUVB-WT quotes

Long-term NUVB-WT plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $7.87MM $62.90MM
Operating Expenses $99.82MM $600.50MM $275.97MM
Operating Income $-99.82MM $-592.63MM $-213.06MM
Non-Operating Income $24.02MM $24.69MM $8.44MM
Interest Expense $0.00MM $0.34MM $13.68MM
R&D Expense $71.29MM $524.19MM $115.11MM
Income(Loss) $-75.80MM $-567.94MM $-204.63MM
Net Income(Loss)* $-75.80MM $-567.94MM $-204.63MM
Stockholders Equity $605.12MM $463.79MM $305.72MM
Inventory $0.00MM $0.00MM $11.41MM
Assets $621.48MM $540.63MM $594.82MM
Operating Cash Flow $-68.00MM $-130.41MM $-173.43MM
Capital expenditure $0.07MM $0.16MM $0.35MM
Investing Cash Flow $8.92MM $122.70MM $99.52MM
Financing Cash Flow $0.63MM $0.33MM $202.53MM
Earnings Per Share** $-0.35 $-2.11 $-0.60

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.